Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories


The high-stakes art of turning cells into drugs

By , Globe Staff

Sophia Koutoulas started as a temporary intern on the shop floor, worked her way up to associate, was promoted to supervisor, and then named director of manufacturing.

Bold Types

Takeda courtyard becomes biotech playground

By , Globe Staff

The lords and ladies of life sciences turned the courtyard outside Takeda Oncology’s headquarters on Landsdowne Street into a biotech playground Thursday.

Biogen seen vulnerable to takeover after sell-off

By , Globe Staff

The Cambridge biotechnology giant now may have to make a bold move to reassure investors.

Biogen loses $20 billion in value after revenue, profit forecasts cut

By , Globe Staff

The biotech is revising expectations for growth as its top-selling multiple sclerosis drug faces tougher competition.